Three insights:
1. Spinevisc is a biomimetic hyaluronic acid product to treat spinal facet joint arthrosis.
2. The product has a medium molecular weight similar to the body’s synovial fluids.
3. The company hopes Spinevisc will open new distribution channels and reach new target groups such as spine surgeons, interventional pain therapists and neuroradiologists.
More articles on bilogics:
Dr. Isaac Karikari: Changing attitudes toward opioids and how physicians can drive change
Dr. Timothy Kremchek to operate on Reds rookie Nick Senzel — 4 insights
Icotec to introduce new pedicle screw system — 4 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
